nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—Stomach ache—Octreotide—thymus cancer	0.0692	0.0759	CcSEcCtD
Glipizide—Jaundice cholestatic—Octreotide—thymus cancer	0.0335	0.0367	CcSEcCtD
Glipizide—Cramps of lower extremities—Octreotide—thymus cancer	0.027	0.0296	CcSEcCtD
Glipizide—Urine output increased—Octreotide—thymus cancer	0.0266	0.0292	CcSEcCtD
Glipizide—Polyuria—Octreotide—thymus cancer	0.0243	0.0267	CcSEcCtD
Glipizide—Visual disturbance—Octreotide—thymus cancer	0.0225	0.0247	CcSEcCtD
Glipizide—Hypoglycaemia—Octreotide—thymus cancer	0.0219	0.024	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.0213	0.0234	CcSEcCtD
Glipizide—Abdominal pain upper—Octreotide—thymus cancer	0.0195	0.0214	CcSEcCtD
Glipizide—Abdominal discomfort—Octreotide—thymus cancer	0.0177	0.0194	CcSEcCtD
Glipizide—Dysuria—Octreotide—thymus cancer	0.0172	0.0189	CcSEcCtD
Glipizide—Drowsiness—Octreotide—thymus cancer	0.0164	0.018	CcSEcCtD
Glipizide—Jaundice—Octreotide—thymus cancer	0.016	0.0176	CcSEcCtD
Glipizide—Conjunctivitis—Octreotide—thymus cancer	0.016	0.0175	CcSEcCtD
Glipizide—Hepatobiliary disease—Octreotide—thymus cancer	0.0156	0.0171	CcSEcCtD
Glipizide—Rhinitis—Octreotide—thymus cancer	0.0148	0.0162	CcSEcCtD
Glipizide—Hepatitis—Octreotide—thymus cancer	0.0148	0.0162	CcSEcCtD
Glipizide—Hypoaesthesia—Octreotide—thymus cancer	0.0147	0.0161	CcSEcCtD
Glipizide—Pharyngitis—Octreotide—thymus cancer	0.0147	0.0161	CcSEcCtD
Glipizide—Visual impairment—Octreotide—thymus cancer	0.0142	0.0156	CcSEcCtD
Glipizide—Flushing—Octreotide—thymus cancer	0.0137	0.015	CcSEcCtD
Glipizide—Arrhythmia—Octreotide—thymus cancer	0.0132	0.0145	CcSEcCtD
Glipizide—Erythema—Octreotide—thymus cancer	0.0129	0.0141	CcSEcCtD
Glipizide—Flatulence—Octreotide—thymus cancer	0.0127	0.0139	CcSEcCtD
Glipizide—Tension—Octreotide—thymus cancer	0.0126	0.0138	CcSEcCtD
Glipizide—Nervousness—Octreotide—thymus cancer	0.0125	0.0137	CcSEcCtD
Glipizide—Muscle spasms—Octreotide—thymus cancer	0.0124	0.0136	CcSEcCtD
Glipizide—Vision blurred—Octreotide—thymus cancer	0.0121	0.0133	CcSEcCtD
Glipizide—Tremor—Octreotide—thymus cancer	0.012	0.0132	CcSEcCtD
Glipizide—Ill-defined disorder—Octreotide—thymus cancer	0.0119	0.0131	CcSEcCtD
Glipizide—Malaise—Octreotide—thymus cancer	0.0116	0.0127	CcSEcCtD
Glipizide—Vertigo—Octreotide—thymus cancer	0.0115	0.0127	CcSEcCtD
Glipizide—Syncope—Octreotide—thymus cancer	0.0115	0.0126	CcSEcCtD
Glipizide—Loss of consciousness—Octreotide—thymus cancer	0.0113	0.0124	CcSEcCtD
Glipizide—Hypertension—Octreotide—thymus cancer	0.0111	0.0122	CcSEcCtD
Glipizide—Arthralgia—Octreotide—thymus cancer	0.0109	0.012	CcSEcCtD
Glipizide—Myalgia—Octreotide—thymus cancer	0.0109	0.012	CcSEcCtD
Glipizide—Anxiety—Octreotide—thymus cancer	0.0109	0.012	CcSEcCtD
Glipizide—Discomfort—Octreotide—thymus cancer	0.0108	0.0119	CcSEcCtD
Glipizide—Oedema—Octreotide—thymus cancer	0.0105	0.0115	CcSEcCtD
Glipizide—Shock—Octreotide—thymus cancer	0.0103	0.0113	CcSEcCtD
Glipizide—Thrombocytopenia—Octreotide—thymus cancer	0.0103	0.0113	CcSEcCtD
Glipizide—Hyperhidrosis—Octreotide—thymus cancer	0.0101	0.0111	CcSEcCtD
Glipizide—Anorexia—Octreotide—thymus cancer	0.01	0.011	CcSEcCtD
Glipizide—KCNJ11—hematopoietic system—thymus cancer	0.00971	0.11	CbGeAlD
Glipizide—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00956	0.0105	CcSEcCtD
Glipizide—Insomnia—Octreotide—thymus cancer	0.00949	0.0104	CcSEcCtD
Glipizide—Paraesthesia—Octreotide—thymus cancer	0.00942	0.0103	CcSEcCtD
Glipizide—Dyspnoea—Octreotide—thymus cancer	0.00935	0.0103	CcSEcCtD
Glipizide—Somnolence—Octreotide—thymus cancer	0.00933	0.0102	CcSEcCtD
Glipizide—Dyspepsia—Octreotide—thymus cancer	0.00923	0.0101	CcSEcCtD
Glipizide—PPARG—neck—thymus cancer	0.00917	0.104	CbGeAlD
Glipizide—Decreased appetite—Octreotide—thymus cancer	0.00912	0.01	CcSEcCtD
Glipizide—Gastrointestinal disorder—Octreotide—thymus cancer	0.00906	0.00994	CcSEcCtD
Glipizide—Constipation—Octreotide—thymus cancer	0.00897	0.00984	CcSEcCtD
Glipizide—Pain—Octreotide—thymus cancer	0.00897	0.00984	CcSEcCtD
Glipizide—Feeling abnormal—Octreotide—thymus cancer	0.00864	0.00948	CcSEcCtD
Glipizide—Gastrointestinal pain—Octreotide—thymus cancer	0.00858	0.00941	CcSEcCtD
Glipizide—Urticaria—Octreotide—thymus cancer	0.00833	0.00914	CcSEcCtD
Glipizide—Abdominal pain—Octreotide—thymus cancer	0.00829	0.0091	CcSEcCtD
Glipizide—Hypersensitivity—Octreotide—thymus cancer	0.00773	0.00848	CcSEcCtD
Glipizide—Asthenia—Octreotide—thymus cancer	0.00753	0.00826	CcSEcCtD
Glipizide—Pruritus—Octreotide—thymus cancer	0.00742	0.00814	CcSEcCtD
Glipizide—Diarrhoea—Octreotide—thymus cancer	0.00718	0.00787	CcSEcCtD
Glipizide—Dizziness—Octreotide—thymus cancer	0.00694	0.00761	CcSEcCtD
Glipizide—KCNJ11—lymphoid tissue—thymus cancer	0.00684	0.0773	CbGeAlD
Glipizide—PPARG—hematopoietic system—thymus cancer	0.00683	0.0772	CbGeAlD
Glipizide—Vomiting—Octreotide—thymus cancer	0.00667	0.00732	CcSEcCtD
Glipizide—ABCC8—pituitary gland—thymus cancer	0.00663	0.075	CbGeAlD
Glipizide—Rash—Octreotide—thymus cancer	0.00661	0.00726	CcSEcCtD
Glipizide—Dermatitis—Octreotide—thymus cancer	0.00661	0.00725	CcSEcCtD
Glipizide—Headache—Octreotide—thymus cancer	0.00657	0.00721	CcSEcCtD
Glipizide—PPARG—epithelium—thymus cancer	0.00624	0.0705	CbGeAlD
Glipizide—Nausea—Octreotide—thymus cancer	0.00623	0.00684	CcSEcCtD
Glipizide—KCNJ11—thyroid gland—thymus cancer	0.00621	0.0702	CbGeAlD
Glipizide—ABCC8—thyroid gland—thymus cancer	0.00572	0.0646	CbGeAlD
Glipizide—PPARG—lymphoid tissue—thymus cancer	0.00481	0.0543	CbGeAlD
Glipizide—PPARG—bone marrow—thymus cancer	0.00438	0.0495	CbGeAlD
Glipizide—PPARG—thyroid gland—thymus cancer	0.00437	0.0493	CbGeAlD
Glipizide—CYP2C9—hematopoietic system—thymus cancer	0.004	0.0452	CbGeAlD
Glipizide—PPARG—lung—thymus cancer	0.00397	0.0448	CbGeAlD
Glipizide—KCNJ11—lymph node—thymus cancer	0.00386	0.0436	CbGeAlD
Glipizide—CYP3A4—hematopoietic system—thymus cancer	0.00305	0.0345	CbGeAlD
Glipizide—PPARG—lymph node—thymus cancer	0.00271	0.0307	CbGeAlD
